Cargando…

Improved outcome in children with advanced stage B-cell non-Hodgkin's lymphoma (B-NHL): results of the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocol

From July 1990 to March 1996, 112 children with stage III or IV B-cell non-Hodgkin's lymphoma (B-NHL) with up to 70% FAB L3-type blasts (n= 42) in the bone marrow without central nervous system (CNS) disease were treated on the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocol (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Atra, A, Imeson, J D, Hobson, R, Gerrard, M, Hann, I M, Eden, O B, Carter, R L, Pinkerton, C R
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2000
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363364/ https://www.ncbi.nlm.nih.gov/pubmed/10780517 http://dx.doi.org/10.1054/bjoc.1999.1083

Ejemplares similares

Improved cure rate in children with B-cell acute lymphoblastic leukaemia (B-ALL) and stage IV B-cell non-Hodgkin's lymphoma (B-NHL)--results of the UKCCSG 9003 protocol.
por: Atra, A., et al.
Publicado: (1998)

Outcome in stage III non-Hodgkin's lymphoma in children (UKCCSG study NHL 86)--how much treatment is needed? United Kingdom Children's Cancer Study Group.
por: Pinkerton, C. R., et al.
Publicado: (1991)

The treatment of Wilms' tumour: results of the United Kingdom Children's Cancer Study Group (UKCCSG) second Wilms' tumour study
por: Mitchell, C, et al.
Publicado: (2000)

Recruiting children into cancer trials–role of the United Kingdom Children's Cancer Study Group (UKCCSG)
por: Ablett, S, et al.
Publicado: (2003)

Adjuvant low dose radiation in childhood non-Hodgkin's lymphoma (report from the United Kingdom Childrens' Cancer Study Group--UKCCSG).
por: Mott, M. G., et al.
Publicado: (1984)

Second malignancies in children treated for non-Hodgkin's lymphoma and T-cell leukaemia with the UKCCSG regimens.
por: Ingram, L., et al.
Publicado: (1987)

Childhood T-cell lymphoblastic lymphoma--does early resolution of mediastinal mass predict for final outcome? The United Kingdom Children's Cancer Study Group (UKCCSG).
por: Shepherd, S. F., et al.
Publicado: (1995)

Risk factors for nephrotoxicity after ifosfamide treatment in children: a UKCCSG Late Effects Group study
por: Skinner, R, et al.
Publicado: (2000)

Non-Hodgkin Lymphoma (NHL) in Pakistan
por: Pervez, Shahid
Publicado: (2012)

Adjuvant low dose radiation in childhood T cell leukaemia/lymphoma (report from the United Kingdom Childrens' Cancer Study Group--UKCCSG).
por: Mott, M. G., et al.
Publicado: (1984)

Childhood cancer and ethnic group in Britain: a United Kingdom children's Cancer Study Group (UKCCSG) study.
por: Stiller, C. A., et al.
Publicado: (1991)

Assessment of bone marrow infiltration in B-cell non-Hodgkin's lymphoma (NHL).
por: Dorey, E. L., et al.
Publicado: (1989)

The Future of Natural Killer Cell Immunotherapy for B Cell Non-Hodgkin Lymphoma (B Cell NHL)
por: Chu, Yaya, et al.
Publicado: (2022)

Targeting Asparagine and Serine Metabolism in Germinal Centre-Derived B Cells Non-Hodgkin Lymphomas (B-NHL)
por: Eraslan, Zuhal, et al.
Publicado: (2021)

A phase I study of nolatrexed dihydrochloride in children with advanced cancer. A United Kingdom Children's Cancer Study Group Investigation
por: Estlin, E J, et al.
Publicado: (2001)

Dose-adjusted EPOCH-rituximab or intensified B-non-Hodgkin lymphoma therapy for pediatric primary mediastinal large B-cell lymphoma. Results from the study B-NHL-BFM-04 and the NHL-BFM registry 2012
por: Knörr, Fabian, et al.
Publicado: (2021)

BCL-6 and other genomic alterations in non-Hodgkin's lymphoma (NHL).
por: Butler, M., et al.
Publicado: (1997)

Familial Aggregation of Non-Hodgkin's Lymphoma (NHL). A Case Report
por: Loves, Sandra SCM, et al.
Publicado: (2006)

Norma de calidad ISO 9002
por: Cuéllar Muñoz, Abel
Publicado: (2003)

A randomized trial of 13-Cis retinoic acid in children with advanced neuroblastoma after high-dose therapy
por: Kohler, J A, et al.
Publicado: (2000)

Neurofibromatosis and childhood leukaemia/lymphoma: a population-based UKCCSG study.
por: Stiller, C. A., et al.
Publicado: (1994)

Herbicide use in farming and other jobs in relation to non-Hodgkin’s lymphoma (NHL) risk
por: De Roos, Anneclaire J, et al.
Publicado: (2022)

Auditoría interna de calidad ISO-9002
por: Cruz Coba, Heidy Guadalupe
Publicado: (1999)

Evaluation of Bone Mineral Density in Children with Acute Lymphoblastic Leukemia (ALL) and Non-Hodgkin's Lymphoma (NHL): Chemotherapy with/without Radiotherapy
por: Ghassemi, Ali, et al.
Publicado: (2016)

Spatial-temporal analysis of non-Hodgkin lymphoma in the NCI-SEER NHL case-control study
por: Wheeler, David C, et al.
Publicado: (2011)

Analysis of Environmental Chemical Mixtures and Non-Hodgkin Lymphoma Risk in the NCI-SEER NHL Study
por: Czarnota, Jenna, et al.
Publicado: (2015)

Quality management systems: the benefits of achieving ISO 9002
por: Wheaton, M, et al.
Publicado: (2000)

Survival among AIDS patients with and without non-Hodgkin's lymphoma, and NHL-HIV-negative patients
por: Cornejo-Juárez, Patricia, et al.
Publicado: (2007)

Anti-Spike (S) Antibody Production Post Covid-19 Vaccination after B Cell Depleting Therapy (BCDT) for Non-Hodgkin Lymphoma (NHL)
por: Molina, Josselyn Glamyr
Publicado: (2021)

Single Nucleotide Polymorphisms in MIR143 Contribute to Protection against Non-Hodgkin Lymphoma (NHL) in Caucasian Populations
por: Bradshaw, Gabrielle, et al.
Publicado: (2019)

Treatment Outcomes of Childhood Medulloblastoma with the SIOP/UKCCSG PNET-3 Protocol
por: Kartal, İbrahim, et al.
Publicado: (2023)

Angiogenesis extent and macrophage density increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas
por: Vacca, A, et al.
Publicado: (1999)

Efficacy and safety of lipegfilgrastim versus pegfilgrastim in elderly patients with aggressive B cell non-Hodgkin lymphoma (B-NHL): results of the randomized, open-label, non-inferiority AVOID neutropenia study
por: Link, Hartmut, et al.
Publicado: (2020)

Characteristics of Central Nervous System (CNS) Involvement in Children With Non-Hodgkin’s Lymphoma (NHL) and the Diagnostic Value of CSF Flow Cytometry in CNS Positive Disease
por: Huang, Shuang, et al.
Publicado: (2021)

Outcome of children with resistant and relapsed Hodgkin's disease.
por: James, N. D., et al.
Publicado: (1992)

Cyclophosphamide pharmacokinetics and pharmacogenetics in children with B-cell non-Hodgkin's lymphoma
por: Veal, Gareth J., et al.
Publicado: (2016)

Diffuse large B-cell non-Hodgkin lymphomas: the clinical relevance of histological subclassification
por: Baars, J W, et al.
Publicado: (1999)

NHL - Extranodal T-cell lymphoma
por: Devi, Seema, et al.
Publicado: (2015)

B-Cell NHL Subtype Risk Associated with Autoimmune Conditions and PRS
por: Wang, Sophia S., et al.
Publicado: (2022)

PB2393: ACTIVATION OF ER STRESS AND UNFOLDED PROTEIN RESPONSE (UPR) PATHWAYS IN HEPATITIS B VIRUS (HBV) INFECTED B CELLS AND ITS SIGNIFICANCE IN PATHOGENESIS OF B-CELL NON-HODGKIN LYMPHOMAS (B-NHL)
por: Uta, Mihaela, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m6q6uk4vhsmhl4mkg48mcp4e2r